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Suppressive activity of human regulatory T cells is maintained in the presence of TNF
To the Editor: Drugs that block tumor necrosis factor (TNF) have been used with success in the treatment of different autoimmune and inflammatory diseases, such as rheumatoid arthritis, Crohn's disease and psoriasis. However, some patients do not respond to these treatments, and a few develop autoimmune responses for unknown reasons. Given that regulatory T reg cell ratios (right) using an APC-and platebound CD3-specific antibody assay (e, five different donors) or a bead assay (f, three different donors). *P < 0.05, **P < 0.01, ****P < 0.0001, obtained using nonparametric one-sided Wilcoxon signed-rank tests.
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the presence of TNF, as assessed in different labs and under different assay conditions (three different suppressive assays, various durations of preincubations, with or without IL-2) using cells from more than 28 different healthy donors. This conclusion is further supported by the fact that TNF increased the expression of CD25 and FOXP3 in human T reg cells in the presence of IL-2 ( Fig. 1c,d) ; furthermore, T reg cells that exhibit the greatest suppressive activity are the ones expressing the highest level of tumor necrosis factor receptor 2 (TNFR2) in both mice and humans 2, 11 . Our findings remain compatible with the results of studies looking at the long-term effects of treatments that block TNF, which reported an increased number and enhanced function of T reg cells 12, 13 . Indeed, it has been suggested that these observations were due to an increase in the differentiation of induced T reg cells, rather than to a direct effect of TNF on natural T reg cells 13 . Overall, we conclude that TNF does not inhibit the suppressive activity of human T reg cells.
METHODS
Methods and any associated references are available in the online version of the paper. 
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The authors declare no competing financial interests. T (T reg ) cells expressing forkhead box P3 (FOXP3) have a major role in regulating autoimmune diseases, and that the production of TNF is increased in these diseases, the effect of TNF on T reg cells is of interest. In previous studies, we looked at different conditions both in vitro and in vivo and observed that TNF promoted proliferation of T reg cells while maintaining the cells' suppressive activity in mice [1] [2] [3] . However, experiments performed using human cells reported that TNF inhibited the suppressive activity of T reg cells in vitro, which was associated with either decreased expression or inactivation of FOXP3 (refs. 4-7). Recently, it was shown that TNF, which is produced in the synovial fluid of individuals with rheumatoid arthritis, reduced T reg cell suppressive function 7 .
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To explore whether these conflicting data are due to species differences, we performed experiments with human T reg cells purified from the blood of healthy donors. We observed a minimal decrease in T reg cell-mediated suppression in the presence of TNF by using two different assays, in which T cells were activated by either antigen-presenting cells (APCs) and plate-bound CD3-specific antibodies (Fig. 1a) or CD3-specific and CD28-specific antibody coated-beads (bead assay) (Fig.  1b) . However, as shown previously 8, 9 , incubation with TNF increased human effector T (T eff ) cell proliferation, even in the absence of T reg cells (Supplementary Fig. 1) , which confounded the interpretation of the suppressive assay. To examine the direct effect of TNF on T reg cells, we preincubated T reg cells with TNF before we assessed their suppressive activity. When T reg cells were cultivated alone for 3 d with interleukin-2 (IL-2) to maintain their survival and function, the addition of TNF increased CD25 and FOXP3 expression (Fig. 1c) . TNF did not increase the expression of CD25 or of FOXP3 in the absence of or at very low doses of IL-2 ( Fig. 1d and Supplementary Fig. 2a) . T reg cells that were pretreated with both TNF and IL-2 and then washed twice to eliminate these cytokines before the suppression assay were slightly more efficient at suppressing T eff cells than were control T reg cells that had been pretreated with IL-2 alone using either the APC and plate-bound anti-CD3 or bead suppression assays (Fig. 1e,f) . Similar findings were obtained using a third assay in which T cells were stimulated by APCs and soluble CD3-specific antibodies (Supplementary Fig. 3 ). When IL-2 was omitted from the T reg cell pre-culture, the cells' suppressive activity was reduced, and when TNF was added to the IL-2-free preculture, it did not alter T reg cell suppressive activity (Supplementary Fig.  4 ). When T reg cells were cultured without IL-2 for only 20 h, TNF had no effect on their phenotype (Supplementary Fig. 2b) . Additionally, when T reg cells were cultured for 20 h with or without IL-2 before the suppression assays, the presence of TNF in the pre-culture had no effect on their suppressive function in any assay condition tested (bead; APC and soluble CD3-specific antibodies; or APC and plate-bound CD3-specific antibodies) (Supplementary Fig. 5 ). Finally, in the presence of IL-2, the effects of TNF on human T reg cells were also observed in a 3-day culture of whole CD4 + T cells, which resulted in an increased proportion of T reg cells and the upregulation of FOXP3 expression (Supplementary Fig. 6 ).
In light of these findings, the effect of TNF on human T reg cells should be revisited. Because TNF has co-stimulatory effects on T eff cells, as shown here and previously 8, 9 , T eff cells are probably more resistant to T reg cell-mediated suppression, as we previously reported in mice 10 . In previous reports demonstrating that TNF inhibited the suppressive activity of human T reg cells, the cytokine was present during the suppression assays, and it may have been acting on both T reg and T eff cells 5, 6 . It was recently reported 7 that human T reg cells lost their suppressive activity even when they were exposed to TNF before, but not during, the suppressive assay. We were unable to replicate these findings under similar culture conditions ( Fig. 1f; Supplementary Figs. 4b and 5c,d) . We consistently observed that human T reg cells do not lose their suppressive activity in npg
